| 6.32 -0.37 (-5.53%) | 03-27 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 8.6 | 1-year : | 9.44 |
| Resists | First : | 7.36 | Second : | 8.09 |
| Pivot price | 6.52 |
|||
| Supports | First : | 6.2 | Second : | 5.16 |
| MAs | MA(5) : | 6.52 |
MA(20) : | 6.67 |
| MA(100) : | 6.78  |
MA(250) : | 5.95 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 38.9 |
D(3) : | 36.6 |
| RSI | RSI(14): 39.2 |
|||
| 52-week | High : | 8.09 | Low : | 3.74 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ LFST ] has closed above bottom band by 19.0%. Bollinger Bands are 28.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.69 - 6.72 | 6.72 - 6.75 |
| Low: | 6.19 - 6.23 | 6.23 - 6.26 |
| Close: | 6.26 - 6.32 | 6.32 - 6.38 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Fri, 27 Mar 2026
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - The Globe and Mail
Thu, 26 Mar 2026
LifeStance Health (LFST) officer has 24,255 shares withheld for RSU taxes - Stock Titan
Thu, 19 Mar 2026
LifeStance (NASDAQ: LFST) officer RSU vesting leads to tax withholding - Stock Titan
Thu, 19 Mar 2026
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sat, 14 Mar 2026
Integral Health Asset Management LLC Takes $8.25 Million Position in LifeStance Health Group, Inc. $LFST - MarketBeat
Fri, 06 Mar 2026
LifeStance Health Group, Inc. $LFST Shares Acquired by Vanguard Group Inc. - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 383 (M) |
| Shares Float | 166 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 96.4 (%) |
| Shares Short | 7,780 (K) |
| Shares Short P.Month | 7,990 (K) |
| EPS | 0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.92 |
| Profit Margin | 0.6 % |
| Operating Margin | 4.7 % |
| Return on Assets (ttm) | 0.7 % |
| Return on Equity (ttm) | 0.6 % |
| Qtrly Rev. Growth | 17.3 % |
| Gross Profit (p.s.) | 1.2 |
| Sales Per Share | 3.7 |
| EBITDA (p.s.) | 0.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 146 (M) |
| Levered Free Cash Flow | 113 (M) |
| PE Ratio | 316 |
| PEG Ratio | 0 |
| Price to Book value | 1.61 |
| Price to Sales | 1.7 |
| Price to Cash Flow | 16.55 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|